Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 11.90% vs -49.91% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -23.37% vs -79.96% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 128.33% vs -86.77% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 92.05% vs -38.89% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Kilitch Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 11.90% vs -49.91% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 2.66% vs 3.05% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -23.37% vs -79.96% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -72.77% vs -4.99% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 128.33% vs -86.77% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 33.00% vs -17.41% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 92.05% vs -38.89% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 17.36% vs 364.52% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025